Executive Profiles

Advancing the Science for Minds: Dr. Husseini Manji, J&J

October 23, 2020

Dr. Husseini Manji talks to Pharm Exec about his new role as J&J's Head of Science for Minds and how he hopes to foster new ways to treat dementia and serious mental disorders and provide holistic mental care.

Speed and Sensitivity

October 14, 2020

Anne E. White, president, Lilly Oncology, talks about how the lessons she learned from leading a startup helped her to speed Lilly’s drug development from target identification through successful launch

Stepping Out in Oncology

September 11, 2020

A glimpse inside the latest turn in Liz Barrett’s influential journey as an oncology executive—this time leaving the confines of big pharma to tackle the innovation void in treating urologic cancers.

Tackling a ‘Genius Virus’

August 10, 2020

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.

Central Focus: Targeting Unmet Need in CNS

July 09, 2020

Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.

Rare Insights: Arndt Rolfs, CENTOGENE

June 10, 2020

Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.

HBA's Woman of the Year 2020: A Motivated Mission

April 23, 2020

For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning-and service-focused-mission to fight disease and accelerate the delivery of new medicines.

Habib Bennaceur: Following the Science

March 07, 2020

AstraZeneca’s Habib Bennaceur talks about the key transitions in his career-from local to global-and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.

Jay Galeota: A Better Way to Pharma

February 10, 2020

Veteran pharma leader Jay Galeota shares learnings and perspectives from an off-the-beaten-path career rise-one driven today by a mission to align the industry’s risk-taking approach across the entire drug life cycle.

Putting CADTH on the National and International Stage

January 20, 2020

Leela Barham talks to Dr. Brian O’Rourke, outgoing President and Chief Executive Officer of the Canadian Agency for Drugs and Technologies in Health (CADTH), about his 11 in years in the role.